Expression of OCT4 pseudogenes in human tumours: Lessons from glioma and breast carcinoma

Journal of Pathology

Volumn 223, Issue 5, 2011, Pages 672-682

  Zhao, Shidou ^a   Yuan, Qiuhuan ^a   Hao, Hongbo ^b   Guo, Yuji ^a   Liu, Shangming ^a   Zhang, Yanmin ^a   Wang, Jianli ^a   Liu, Huijuan ^a   Wang, Fuwu ^a   Liu, Kai ^a   Ling, Eng Ang ^c   Hao, Aijun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Breast carcinoma; Glioma; OCT4; Pseudogenes; Tumour cell line

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS; SOLID TUMOR; TUMOR; WESTERN BLOTTING;

ADULT; AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GENES, NEOPLASM; GLIOMA; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PSEUDOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SEQUENCE ALIGNMENT; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 79952550805     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2827     Document Type: Article

References (47)

1. Kang J, Shakya A, Tantin D. Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem Sci 2009; 34: 491-499.
2. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63: 2244-2250. (Pubitemid 36538633)
3. Gidekel S, Pizov G, Bergman Y, et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003; 4: 361-370. (Pubitemid 37491097)
4. de Jong J, Looijenga LH. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 2006; 12: 171-203. (Pubitemid 46524130)
5. Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211: 1-9. (Pubitemid 46092024)
6. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene 2001; 20: 8085-8091. (Pubitemid 34028332)
7. Wang P, Branch DR, Bali M, et al. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J 2003; 375: 199-205. (Pubitemid 37255396)
8. Tai MH, Chang CC, Kiupel M, et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495-502.
9. Ezeh UI, Turek PJ, Reijo RA, et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005; 104: 2255-2265. (Pubitemid 41579973)
10. Atlasi Y, Mowla SJ, Ziaee SA, et al. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007; 120: 1598-1602. (Pubitemid 46355399)
11. Wu CL, Shieh GS, Chang CC, et al. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models. Clin Cancer Res 2008; 14: 1228-1238.
12. Sotomayor P, Godoy A, Smith GJ, et al. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 2009; 69: 401-410.
13. Du Z, Jia D, Liu S, et al. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 2009; 57: 724-733.
14. Gibbs CP, Kukekov VG, Reith JD, et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 2005; 7: 967-976.
15. Webster JD, Yuzbasiyan-Gurkan V, Trosko JE, et al. Expression of the embryonic transcription factor Oct4 in canine neoplasms: a potential marker for stem cell subpopulations in neoplasia. Vet Pathol 2007; 44: 893-900. (Pubitemid 350260709)
16. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085-4095.
17. Hu T, Liu S, Breiter DR, et al. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008; 68: 6533-6540.
18. Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008; 3: e2637.
19. Cantz T, Key G, Bleidissel M, et al. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008; 26: 692-697.
20. Mueller T, Luetzkendorf J, Nerger K, et al. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 2009; 66: 495-503.
21. Palumbo C, van Roozendaal K, Gillis AJ, et al. Expression of the PDGF α-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 2002; 196: 467-477. (Pubitemid 34262860)
22. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282. (Pubitemid 39382161)
23. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828. (Pubitemid 37187480)
24. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988. (Pubitemid 36418143)
25. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902. (Pubitemid 37500174)
26. Takeda J, Seino S, Bell GI. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 1992; 20: 4613-4620.
27. Cauffman G, Liebaers I, Van Steirteghem A, et al. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006; 24: 2685-2691. (Pubitemid 46053006)
28. Lee J, Kim HK, Rho JY, et al. The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 2006; 281: 33554-33565. (Pubitemid 46036736)
29. Pain D, Chirn GW, Strassel C, et al. Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem 2005; 280: 6265-6268. (Pubitemid 40347250)
30. Atlasi Y, Mowla SJ, Ziaee SA, et al. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008; 26: 3068-3074.
31. Suo G, Han J, Wang X, et al. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005; 337: 1047-1051. (Pubitemid 41505231)
32. Liedtke S, Stephan M, Kogler G. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 2008; 389: 845-850.
33. Liedtke S, Enczmann J, Waclawczyk S, et al. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 2007; 1: 364-366. (Pubitemid 47506539)
34. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
35. Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 2010; 220: 263-280.
36. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol 2008; 26: 2568-2581.
37. Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27: 1160-1167.
38. Jia DY, Du ZH, Liu SM, et al. c-Abl is involved in high glucose-induced apoptosis in embryonic E12.5 cortical neural progenitor cells from the mouse brain. J Neurochem 2008; 106: 1720-1730.
39. Brehm A, Ohbo K, Schöler H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol 1997; 17: 154-162. (Pubitemid 26425604)
40. Saxe JP, Tomilin A, Schöler HR, et al. Post-translational regulation of Oct4 transcriptional activity. PLoS One 2009; 4: e4467.
41. Hochedlinger K, Yamada Y, Beard C, et al. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005; 121: 465-477. (Pubitemid 40692305)
42. Lengner CJ, Camargo FD, Hochedlinger K, et al. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007; 1: 403-415. (Pubitemid 47506536)
43. Lengner CJ, Welstead GG, Jaenisch R. The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle 2008; 7: 725-728. (Pubitemid 351520033)
44. Berg JS, Goodell MA. An argument against a role for Oct4 in somatic stem cells. Cell Stem Cell 2007; 1: 359-360.
45. Kotoula V, Papamichos SI, Lambropoulos AF. Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 2008; 26: 290-291.
46. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507. (Pubitemid 351601215)
47. Somervaille TC, Matheny CJ, Spencer GJ, et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009; 4: 129-140.